,
The National Agency for Food and Drug Administration and Control has been informed by Allen & Hanburys (A&H) Pharmaceutical Nigeria Limited on the circulation of falsified Proximexa Suspension (Cefuroxime Axetil 125mg/5ml) Lot Number C830116 in retail outlets in Nigeria.
The falsified Proximexa Suspension 125mg /5ml Lot number C830116 is labelled with fictitious MANFD SEP 2019 and EXP SEP 2022.
The details of the falsified Proximexa Suspension 125mg /5ml are as follows:
| Product Name | Proximexa Suspension 125mg /5ml |
| Stated Manufacturer | Glaxo operations UK Ltd |
| Lot | C830116 |
| MANFD | SEP 2019 |
| EXP | SEP 2022 |
The package label of the falsified Proximexa Suspension 125mg /5ml showing MANFD: SEP 2019 and EXP: 2022 is below
Genuine Proximexa Suspension 125mg /5ml (Cefuroxime Axetil125mg/5ml) Batch Number C830116 manufactured by Glaxo operations UK Ltd has manufacturing date SEP 2017 and Expiry date SEP 2019. The genuine Proximexa Suspension 125mg /5ml Batch Number C830116 expired in SEP 2019.
The genuine Proximexa Suspension 125mg /5ml manufactured by Glaxo operations UK Ltd is registered by NAFDAC with NAFDAC Reg. No: A4-6143
Genuine Proximexa Suspension 125mg /5ml is an antibiotic used to treat a wide variety of bacterial infections including bronchitis, urinary tract infections and pneumonia.
Glaxo operations UK Ltd has confirmed that they did not manufacture the affected falsified Proximexa Suspension 125mg /5ml.
All importers, wholesalers and retailers are implored to desist from illegal importation, distribution and sale of the falsified Proximexa Suspension 125mg /5ml
Surveillance has been strengthened by NAFDAC at all ports of entry to prevent illegal importation of the falsified Proximexa Suspension 125mg /5ml
The Agency has heightened surveillance in the thirty-six States and the Federal Capital Territory, Abuja to prevent distribution and sale of falsified Proximexa Suspension 125mg /5ml
Health care providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified Proximexa Suspension 125mg /5ml
Anybody in possession of the falsified Proximexa Suspension 125mg /5ml should submit it to the nearest NAFDAC office.
Consumers are advised to report adverse events related to use medicines to the nearest NAFDAC office, 0800-1-NAFDAC (0800-1-623322) TOLL FREE from all networks or via pharmacovigilance@nafdac.gov.ng
NAFDAC……..Customer-focused, Agency-minded!!!
Signed Management
